CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 0	$ 0
Operating expense
Research and development	4,133,925	745,945
General and administrative	5,543,173	2,944,377
Total operating expenses	9,677,098	3,690,322
Loss from operations	(9,677,098)	(3,690,322)
Other income (expense)
Interest income	128,762	332,240
Total other income (expense)	128,762	332,240
Net loss	$ (9,548,336)	$ (3,358,082)
Basic and Diluted Loss per Common Share	$ (0.11)	$ (0.04)
Weighted average number of common shares outstanding - basic and diluted	87,352,364	87,237,053